Skip to Main Content
Back to News

Fund Update: SIGNATUREFD, LLC added 14,227 shares of HCA HEALTHCARE ($HCA) to their portfolio

None

SIGNATUREFD, LLC has added 14,227 shares of $HCA to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $HCA.

HCA HEALTHCARE Hedge Fund Activity

We have seen 541 institutional investors add shares of HCA HEALTHCARE stock to their portfolio, and 565 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HCA HEALTHCARE Insider Trading Activity

HCA HEALTHCARE insiders have traded $HCA stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $HCA stock by insiders over the last 6 months:

  • JON M FOSTER (EVP and COO) sold 15,698 shares for an estimated $5,797,660
  • JENNIFER BERRES (SVP & Chief Human Res. Officer) has made 0 purchases and 2 sales selling 9,533 shares for an estimated $3,075,240.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HCA HEALTHCARE Congressional Stock Trading

Members of Congress have traded $HCA stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $HCA stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HCA HEALTHCARE Analyst Ratings

Wall Street analysts have issued reports on $HCA in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Truist Securities issued a "Buy" rating on 07/16/2025
  • RBC Capital issued a "Outperform" rating on 06/23/2025
  • Barclays issued a "Overweight" rating on 06/02/2025
  • B of A Securities issued a "Buy" rating on 05/13/2025
  • Cantor Fitzgerald issued a "Overweight" rating on 01/27/2025

To track analyst ratings and price targets for HCA HEALTHCARE, check out Quiver Quantitative's $HCA forecast page.

HCA HEALTHCARE Price Targets

Multiple analysts have issued price targets for $HCA recently. We have seen 8 analysts offer price targets for $HCA in the last 6 months, with a median target of $407.5.

Here are some recent targets:

  • David Macdonald from Truist Securities set a target price of $415.0 on 07/16/2025
  • Kevin Fischbeck from B of A Securities set a target price of $410.0 on 07/16/2025
  • Ben Hendrix from RBC Capital set a target price of $404.0 on 06/23/2025
  • Craig Hettenbach from Morgan Stanley set a target price of $410.0 on 06/09/2025
  • Andrew Mok from Barclays set a target price of $416.0 on 06/02/2025
  • Stephen Baxter from Wells Fargo set a target price of $385.0 on 05/29/2025
  • Michael Ha from Baird set a target price of $336.0 on 04/15/2025

Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.

Check out Quiver Quantitative's $HCA ticker page for more data.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles